Elsevier

Behavioural Brain Research

Volume 31, Issue 2, 1 December 1988, Pages 135-147
Behavioural Brain Research

Research report
Graded increases in brain GABA: Differential effects on feeding and other behaviours in rats

https://doi.org/10.1016/0166-4328(88)90017-4Get rights and content

Abstract

Elevations of brain γ-aminobutyric acid (GABA) induced by inhibitors of GABA transaminase (GABA-T) are known to induce a number of functional effects including depression of food intake. The aim of the present study was to determine the brain GABA elevation threshold for changes in feeding and several other behaviours, in an effort to clarify whether feeding changes might be secondary to other functional deficits. To this end, various doses of the GABA-T inhibitors ethanolamine-o-sulfate (EOS) and γ-vinyl GABA (GVG) were injected intracisternally and effects on whole brain GABA, food and water intake, open field activity, catalepsy indices, pain sensitivity, and core temperature were assessed 24 h later. Progressive increases in brain GABA levels were found to differentially affect the responses studied. At the low end of the continuum, significant decreases in feeding behaviour were associated with relatively modest increases in brain GABA (40–60%). At higher levels of GABA elevation (> 100%), changes in motoric functions and rectal temperature became apparent. At still higher levels (> 200% increases in brain GABA), significant antinociceptive effects were detected. These results support the notion that feeding decreases induced by low doses of GABA-T inhibitors may reflect a fairly specific effect on appetite mechanisms, but also indicate that with increasingly higher doses several other deficits are likely to contribute to the overall decrease in food intake.

References (45)

  • D.I.B. Kerr et al.

    GABA and GABA-receptors in the enteric nervous system

    Neuropharmacology

    (1984)
  • M.J. Leach et al.

    Effect of ethanolamine-o-sulphate on regional GABA metabolism in the mouse brain

    Biochem. Pharmacol.

    (1977)
  • J.E. Morley et al.

    Muscimol-induced feeding: a model to study the hypothalamic regulation of appetite

    Life Sci.

    (1981)
  • J.N. Nobrega et al.

    Inhibition of acute feeding responses to systemic 2-deoxyglucose or insulin in rats pretreated with the GABA-transaminase blocker ethanolamine-o-sulfate (EOS)

    Pharmacol. Biochem. Behav.

    (1982)
  • M.G. Palfreyman et al.

    The pharmacology of GABA-transaminase inhibitors

    Biochem. Pharmacol.

    (1981)
  • C. Pycock et al.

    Regional changes in the concentrations of cerebral monoamines and their metabolites after ethanolamine-o-sulphate-induced elevation of brain gamma-aminobutyric acid concentration

    Biochem. Pharmacol.

    (1978)
  • E.M. Rimmer et al.

    Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

    Lancet

    (1984)
  • J. Sawynok

    GABAergic mechanisms of analgesia: an update

    Pharmacol. Biochem. Behav.

    (1987)
  • J. Sawynok et al.

    On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine

    Neuropharmacology

    (1982)
  • J. Sawynok et al.

    Involvement of GABA in the antinociceptive effect of gamma-acetylenic GABA (GAG), an inhibitor of GABA-transaminase

    Gen. Pharmacol.

    (1983)
  • P.J. Schechter

    Biochemical and therapeutic effects of GABA-transmainase inhibition: clinical studies with gamma-vinyl GABA

    Neuropharmacology

    (1984)
  • S.M. Stahl et al.

    Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders

    Biol. Psychiatry

    (1985)
  • Cited by (12)

    • GABA and behavior: The role of receptor subtypes

      1992, Neuroscience and Biobehavioral Reviews
    View all citing articles on Scopus
    View full text